Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.
Written by
in